Rhumbline Advisers Catalyst Biosciences, Inc. Transaction History

Rhumbline Advisers

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$4.1 - $5.33 $135,238 - $175,810	-32,985 Closed	0 $0
Q1 2021 May 06, 2021	BUY	$4.93 - $7.15 $16,268 - $23,595	3,300 Added 11.12%	32,985 $166,000
Q4 2020 Feb 10, 2021	BUY	$4.55 - $7.29 $23,623 - $37,849	5,192 Added 21.2%	29,685 $187,000
Q3 2020 Nov 12, 2020	BUY	$4.22 - $6.04 $11,740 - $16,803	2,782 Added 12.81%	24,493 $105,000
Q2 2020 Aug 13, 2020	BUY	$3.76 - $8.01 $81,633 - $173,905	21,711 New	21,711 $127,000
Q2 2019 Aug 14, 2019	SELL	$7.08 - $10.6 $119,085 - $178,292	-16,820 Closed	0 $0
Q1 2019 May 01, 2019	SELL	$7.67 - $9.96 $1,380 - $1,792	-180 Reduced 1.06%	16,820 $136,000
Q4 2018 Jan 31, 2019	BUY	$6.59 - $11.28 $33,740 - $57,753	5,120 Added 43.1%	17,000 $134,000
Q3 2018 Nov 07, 2018	BUY	$9.35 - $12.44 $2,449 - $3,259	262 Added 2.26%	11,880 $128,000
Q2 2018 Aug 06, 2018	BUY	$9.11 - $28.88 $105,839 - $335,527	11,618 New	11,618 $136,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.